Pardes Biosciences Inc. (PRDS)
NASDAQ: PRDS
· Real-Time Price · USD
2.18
0.02 (0.93%)
At close: Aug 30, 2023, 9:59 PM
Pardes Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -10.78M | -17.8M | -24.22M | -23.34M | -27.64M | -21.44M | -14.35M | -11.51M | -8.14M | -4.52M |
Depreciation & Amortization | n/a | n/a | -1.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 1.4M | 2.34M | 2.43M | 2.72M | 3.89M | 1.53M | 571K | 344K | 230K | 76K |
Other Working Capital | -5.99M | 1.21M | 6.74M | 1.19M | 5.11M | -665K | -2.64M | 378K | 885K | 1M |
Other Non-Cash Items | -844K | -1.42M | -1.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -9.69M | -9.64M | 10.1M | 1.07M | 4.43M | -449K | -3M | 568K | 2.12M | 699K |
Operating Cash Flow | -19.91M | -26.53M | -12.75M | -19.54M | -19.32M | -20.36M | -16.78M | -10.6M | -5.79M | -3.75M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -15.76M | -138.2 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 73.01M | 30.18M | 1.18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 73.01M | 14.41M | -137.02 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 396.86K | n/a | n/a | -397K | 259.07M | -848K | -282K | 44.24M |
Financial Cash Flow | n/a | n/a | 396.86K | n/a | n/a | -397K | 259.07M | -848K | -282K | 44.24M |
Net Cash Flow | 53.1M | -12.12M | -149.77M | -19.54M | -19.32M | -20.76M | 242.29M | -11.45M | -6.07M | 40.49M |
Free Cash Flow | -19.91M | -26.53M | -12.75M | -19.54M | -19.32M | -20.36M | -16.78M | -10.6M | -5.79M | -3.75M |